223 related articles for article (PubMed ID: 7702642)
1. Different analogues of farnesyl pyrophosphate inhibit squalene synthase and protein:farnesyltransferase to different extents.
Cohen LH; Valentijn AR; Roodenburg L; Van Leeuwen RE; Huisman RH; Lutz RJ; Van der Marel GA; Van Boom JH
Biochem Pharmacol; 1995 Mar; 49(6):839-45. PubMed ID: 7702642
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human smooth muscle cell proliferation in culture by farnesyl pyrophosphate analogues, inhibitors of in vitro protein: farnesyl transferase.
Cohen LH; Pieterman E; van Leeuwen RE; Du J; Negre-Aminou P; Valentijn AR; Overhand M; van der Marel GA; van Boom JH
Biochem Pharmacol; 1999 Feb; 57(4):365-73. PubMed ID: 9933024
[TBL] [Abstract][Full Text] [Related]
3. Protein farnesyltransferase: measurement of enzymatic activity in 96-well format using TopCount microplate scintillation counting technology.
Harwood HJ
Anal Biochem; 1995 Apr; 226(2):268-78. PubMed ID: 7793628
[TBL] [Abstract][Full Text] [Related]
4. J-104,871, a novel farnesyltransferase inhibitor, blocks Ras farnesylation in vivo in a farnesyl pyrophosphate-competitive manner.
Yonemoto M; Satoh T; Arakawa H; Suzuki-Takahashi I; Monden Y; Kodera T; Tanaka K; Aoyama T; Iwasawa Y; Kamei T; Nishimura S; Tomimoto K
Mol Pharmacol; 1998 Jul; 54(1):1-7. PubMed ID: 9658183
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of farnesyltransferase with A-176120, a novel and potent farnesyl pyrophosphate analogue.
Tahir SK; Gu WZ; Zhang HC; Leal J; Lee JY; Kovar P; Saeed B; Cherian SP; Devine E; Cohen J; Warner R; Wang YC; Stout D; Arendsen DL; Rosenberg S; Ng SC
Eur J Cancer; 2000 Jun; 36(9):1161-70. PubMed ID: 10854950
[TBL] [Abstract][Full Text] [Related]
6. Farnesylation of p21 Ras proteins in Xenopus oocytes.
Zhao J; Kung HF; Manne V
Cell Mol Biol Res; 1994; 40(4):313-21. PubMed ID: 7866432
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of farnesyl transferases from malignant and non-malignant cultured human lymphocytes by prenyl substrate analogues.
Das NP; Allen CM
Biochem Biophys Res Commun; 1991 Dec; 181(2):729-35. PubMed ID: 1755854
[TBL] [Abstract][Full Text] [Related]
8. Stereochemistry-dependent inhibition of RAS farnesylation by farnesyl phosphonic acids.
Hohl RJ; Lewis KA; Cermak DM; Wiemer DF
Lipids; 1998 Jan; 33(1):39-46. PubMed ID: 9470172
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of a transferable farnesyl pyrophosphate analogue to Ras by protein farnesyltransferase.
Chehade KA; Andres DA; Morimoto H; Spielmann HP
J Org Chem; 2000 May; 65(10):3027-33. PubMed ID: 10814193
[TBL] [Abstract][Full Text] [Related]
10. Hydrophilic anilinogeranyl diphosphate prenyl analogues are Ras function inhibitors.
Roberts MJ; Troutman JM; Chehade KA; Cha HC; Kao JP; Huang X; Zhan CG; Peterson YK; Subramanian T; Kamalakkannan S; Andres DA; Spielmann HP
Biochemistry; 2006 Dec; 45(51):15862-72. PubMed ID: 17176109
[TBL] [Abstract][Full Text] [Related]
11. Farnesyl diphosphate-based inhibitors of Ras farnesyl protein transferase.
Patel DV; Schmidt RJ; Biller SA; Gordon EM; Robinson SS; Manne V
J Med Chem; 1995 Jul; 38(15):2906-21. PubMed ID: 7636851
[TBL] [Abstract][Full Text] [Related]
12. Farnesyl-derived inhibitors of ras farnesyl transferase.
Kang MS; Stemerick DM; Zwolshen JH; Harry BS; Sunkara PS; Harrison BL
Biochem Biophys Res Commun; 1995 Dec; 217(1):245-9. PubMed ID: 8526918
[TBL] [Abstract][Full Text] [Related]
13. Zaragozic acids D and D2: potent inhibitors of squalene synthase and of Ras farnesyl-protein transferase.
Dufresne C; Wilson KE; Singh SB; Zink DL; Bergstrom JD; Rew D; Polishook JD; Meinz M; Huang L; Silverman KC
J Nat Prod; 1993 Nov; 56(11):1923-9. PubMed ID: 8289063
[TBL] [Abstract][Full Text] [Related]
14. Polyisoprenylation of Ras in vitro by a farnesyl-protein transferase.
Schaber MD; O'Hara MB; Garsky VM; Mosser SC; Bergstrom JD; Moores SL; Marshall MS; Friedman PA; Dixon RA; Gibbs JB
J Biol Chem; 1990 Sep; 265(25):14701-4. PubMed ID: 2203759
[TBL] [Abstract][Full Text] [Related]
15. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
[TBL] [Abstract][Full Text] [Related]
16. Nonidentical subunits of p21H-ras farnesyltransferase. Peptide binding and farnesyl pyrophosphate carrier functions.
Reiss Y; Seabra MC; Armstrong SA; Slaughter CA; Goldstein JL; Brown MS
J Biol Chem; 1991 Jun; 266(16):10672-7. PubMed ID: 2037606
[TBL] [Abstract][Full Text] [Related]
17. Isoprenoid (phosphinylmethyl)phosphonates as inhibitors of squalene synthetase.
Biller SA; Forster C; Gordon EM; Harrity T; Scott WA; Ciosek CP
J Med Chem; 1988 Oct; 31(10):1869-71. PubMed ID: 3172121
[No Abstract] [Full Text] [Related]
18. Phosphonate and bisphosphonate analogues of farnesyl pyrophosphate as potential inhibitors of farnesyl protein transferase.
Holstein SA; Cermak DM; Wiemer DF; Lewis K; Hohl RJ
Bioorg Med Chem; 1998 Jun; 6(6):687-94. PubMed ID: 9681134
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides.
Reiss Y; Goldstein JL; Seabra MC; Casey PJ; Brown MS
Cell; 1990 Jul; 62(1):81-8. PubMed ID: 2194674
[TBL] [Abstract][Full Text] [Related]
20. A rapid and convenient filter-binding assay for ras p21 processing enzyme farnesyltransferase.
Khan SG; Mukhtar H; Agarwal R
J Biochem Biophys Methods; 1995 Jun; 30(2-3):133-44. PubMed ID: 7494090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
